Research ArticleArticle

Disease Activity and Increased Risk of Cardiovascular Death among Patients with Psoriatic Arthritis

Kristina Juneblad, Solbritt Rantapää-Dahlqvist and Gerd-Marie Alenius
The Journal of Rheumatology December 2016, 43 (12) 2155-2161; DOI: https://doi.org/10.3899/jrheum.160070

REFERENCES

  1. 1.↵
    1. Bengtsson C,
    2. Öhman ML,
    3. Nived O,
    4. Rantapää Dahlqvist S
    . Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study. Lupus 2012;21:452–9.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Wållberg-Jonnson S,
    2. Johansson H,
    3. Öhman ML,
    4. Rantapää-Dahlqvist S
    . Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562–71.
    OpenUrlPubMed
  3. 3.↵
    1. Innala L,
    2. Möller B,
    3. Ljung L,
    4. Magnusson S,
    5. Smedby T,
    6. Södergren A,
    7. et al.
    Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 2011;15:R131.
    OpenUrl
  4. 4.↵
    1. Meune C,
    2. Touze E,
    3. Trinquart L,
    4. Allanore Y
    . Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2009;48:1309–13.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Alenius GM,
    2. Stegmayr BG,
    3. Dahlqvist SR
    . Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol 2001;30:271–4.
    OpenUrlPubMed
  6. 6.↵
    1. Tobin AM,
    2. Veale DJ,
    3. Fitzgerald O,
    4. Rogers S,
    5. Collins P,
    6. O’Shea D,
    7. et al.
    Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. J Rheumatol 2010;37:1386–94.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Gladman DD,
    2. Ang M,
    3. Su L,
    4. Tom BD,
    5. Schentag CT,
    6. Farewell VT
    . Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009;68:1131–5.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Ahlehoff O,
    2. Gislason GH,
    3. Charlot M,
    4. Jorgensen CH,
    5. Lindhardsen J,
    6. Olesen JB,
    7. et al.
    Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011;270:147–57.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Jamnitski A,
    2. Symmons D,
    3. Peters MJ,
    4. Sattar N,
    5. McInnes I,
    6. Nurmohamed MT
    . Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2013;72:211–6.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Horreau C,
    2. Pouplard C,
    3. Brenaut E,
    4. Barnetche T,
    5. Misery L,
    6. Cribier B,
    7. et al.
    Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 2013;27 Suppl 3:12–29.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Miller IM,
    2. Ellervik C,
    3. Yazdanyar S,
    4. Jemec GB
    . Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 2013;69:1014–24.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Eder L,
    2. Wu Y,
    3. Chandran V,
    4. Cook R,
    5. Gladman DD
    . Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Ann Rheum Dis 2016;75:1680–6.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Eder L,
    2. Zisman D,
    3. Barzilai M,
    4. Laor A,
    5. Rahat M,
    6. Rozenbaum M,
    7. et al.
    Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 2008;35:877–82.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Eder L,
    2. Jayakar J,
    3. Shanmugarajah S,
    4. Thavaneswaran A,
    5. Pereira D,
    6. Chandran V,
    7. et al.
    The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with psoriasis alone. Ann Rheum Dis 2013;72:715–20.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Costa L,
    2. Caso F,
    3. D’Elia L,
    4. Atteno M,
    5. Peluso R,
    6. Del Puente A,
    7. et al.
    Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol 2012;31:711–5.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Shen J,
    2. Shang Q,
    3. Li EK,
    4. Leung YY,
    5. Kun EW,
    6. Kwok LW,
    7. et al.
    Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. Arthritis Res Ther 2015;17:75.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Di Minno MN,
    2. Ambrosino P,
    3. Lupoli R,
    4. Di Minno A,
    5. Tasso M,
    6. Peluso R,
    7. et al.
    Cardiovascular risk markers in patients with psoriatic arthritis: a meta-analysis of literature studies. Ann Med 2015;47:346–53.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Gladman DD
    . Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008;26 Suppl 51:S62–5.
    OpenUrlPubMed
  19. 19.↵
    1. Wong K,
    2. Gladman DD,
    3. Husted J,
    4. Long JA,
    5. Farewell VT
    . Mortality studies in psoriatic arthritis. Results from a single outpatient center. I. Causes and risk of death. Arthritis Rheum 1997;40:1868–72.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Gladman DD,
    2. Farewell VT,
    3. Wong K,
    4. Husted J
    . Mortality studies in psoriatic arthritis. Results from a single outpatient center II. Prognostic indicators for death. Arthritis Rheum 1998;41:1103–10.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Coulton BL,
    2. Thomson K,
    3. Symmons DP,
    4. Popert AJ
    . Outcome in patients hospitalised for psoriatic arthritis. Clin Rheumatol 1989;8:261–5.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Shbeeb M,
    2. Uramoto KM,
    3. Gibson LE,
    4. O’Fallon WM,
    5. Gabriel SE
    . The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 2000;27:1247–50.
    OpenUrlPubMed
  23. 23.↵
    1. Ogdie A,
    2. Haynes K,
    3. Troxel AB,
    4. Love TJ,
    5. Hennessy S,
    6. Choi H,
    7. et al.
    Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis 2014;73:149–53.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Baecklund E,
    2. Sundström C,
    3. Ekbom A,
    4. Catrina AI,
    5. Biberfeld P,
    6. Feltelius N,
    7. et al.
    Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of large B cell lymphoma. Arthritis Rheum 2003;48:1543–50.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Ali Y,
    2. Tom BD,
    3. Schentag CT,
    4. Farewell VT,
    5. Gladman DD
    . Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007;56:2708–14.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Bakland G,
    2. Gran JT,
    3. Nossent C
    . Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011;70:1921–5.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Libby P,
    2. Ritker PM,
    3. Hansson GK
    . Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129–38.
    OpenUrlFREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

PSORIATIC ARTHRITIS
MORTALITY
CARDIOVASCULAR DISEASES
EPIDEMIOLOGY
DISEASE ACTIVITY

Keywords